TrademarkDir
SPARROW PHARMACEUTICALS
DEAD

Serial Number

88817597

Owner

Sparrow Pharmaceuticals, Inc.

Attorney

Sean D. O'Brien

Filing Date

Mar 2, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SPARROW PHARMACEUTICALS Trademark

Serial Number: 88817597

SPARROW PHARMACEUTICALS is a trademark filed by Sparrow Pharmaceuticals, Inc. on March 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Sparrow Pharmaceuticals, Inc. (5 trademarks)

2041 W Shakespeare Ave
Chicago, IL 60647

Entity Type: 03

Trademark Details

Filing Date

March 2, 2020

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment and prevention of allergic states, collagen diseases, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematological disorders, infectious diseases, neoplastic diseases, nervous system disorders, ophthalmic diseases, respiratory disorders, and rheumatic disorders

Filing History

ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jan 10, 2023 MAB3
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jan 10, 2023 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Jan 10, 2023 ABN3
EXPARTE APPEAL TERMINATED
Jan 10, 2023 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Nov 23, 2022 EXFB
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Aug 26, 2022 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Aug 26, 2022 GECD
ACTION CONTINUING FINAL - COMPLETED
Aug 26, 2022 CNCF
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 18, 2022 JURT
EX PARTE APPEAL-INSTITUTED
May 24, 2022 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 24, 2022 JURT
EXPARTE APPEAL RECEIVED AT TTAB
May 20, 2022 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 22, 2021 GNFN
FINAL REFUSAL E-MAILED
Nov 22, 2021 GNFR
FINAL REFUSAL WRITTEN
Nov 22, 2021 CNFR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 24, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 23, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 23, 2020 GNSL
SUSPENSION LETTER WRITTEN
Nov 23, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2020 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 5, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 5, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 5, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 5, 2020 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 27, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 27, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 27, 2020 CNRT
ASSIGNED TO EXAMINER
May 20, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2020 NWOS
NEW APPLICATION ENTERED
Mar 5, 2020 NWAP

Related Trademarks

More from this Owner

SPARROW PHARMACEUTICALS logo

SPARROW PHARMACEUTICALS

Trademark logo

Serial #90635893

Trademark logo

Serial #90635893

Trademark logo

Serial #90635893

NEXT-GEN STEROIDS

NEXT-GEN STEROIDS

SPARROW PHARMACEUTICALS

SPARROW PHARMACEUTICALS